Windham Capital Partners (formerly Windham Venture Partners) is a New York City-based venture capital firm focused on healthcare, with a particular emphasis on medical technology and digital health. Founded in 2006, the firm invests in companies developing life-saving and game-changing technologies across pharmaceutical, medical device, and digital health markets.
41% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Average disclosed round size is $53.2M (across 23 rounds with reported amounts).
Portfolio
20
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Alistair Erskine
Operating Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
29 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 PainTEQ | Growth | — | Aug 2025 |
 Clever Care | Unknown | $42M | Jan 2023 |
 Valera Health | Growth | $44.5M | Oct 2022 |
 Vergent Bioscience | Series B | $21.5M | Oct 2022 |
| DDelfi Diagnostics, Inc. | Series B | — | Jul 2022 |
 Delfi | Series B | — | Jul 2022 |
| Delfi | Series B | $225M | Jan 2022 |
| Clever Care | Series B | $71M | Sep 2021 |
| Valera Health | Seed | $3.8M | Feb 2021 |
 Delfi Diagnostics | Series A | $100M | Jan 2021 |
 NeuSpera | Series B | $26M | Feb 2019 |
 Nuvaira | Series C | $79M | Feb 2019 |
| NNuvaira, Inc. | Unknown | $79M | Jan 2019 |
 Nebula Genomics | Series A | — | Aug 2018 |
 EarLens | Series C | $73M | Jun 2017 |
 Coravin | Series C | $13.6M | Jan 2016 |
 Welldoc | Series B | $22M | Dec 2015 |
| PPersonal Genome Diagnostics (PGDx) | Series A | $21.4M | Oct 2015 |
| PPGDx | Series A | $21.4M | Jan 2015 |
| VVytronUS | Series B | $31.6M | Oct 2014 |
| HHolaira | Series C | $10M | Feb 2013 |
| PainTEQ | Unknown | — | — |
 TailorMed | Unknown | $40M | — |
| DDelfi Diagnostics, Inc. | Series A | $100M | — |
| DDelfi Diagnostics, Inc. | Seed | $5.5M | — |
Page 1 of 2
Top Co-Investors
Northpond Ventures7 shared
Illumina Ventures6 shared
Menlo Ventures6 shared
AV8 Ventures6 shared
Samsara BioCapital6 shared
Cowen Healthcare Investments5 shared
Rock Springs Capital5 shared
New Enterprise Associates4 shared
Morgenthaler Ventures4 shared
Split Rock Partners4 shared
Versant Ventures4 shared
T. Rowe Price4 shared
OrbiMed4 shared
Foresite Capital4 shared
Lightstone Ventures3 shared
Open Field Capital3 shared
Osage University Partners3 shared
Eli Lilly and Company3 shared
Advanced Technology Ventures3 shared
AVP2 shared
Last updated: 8 September 2026